As previously reported last night, Cantor Fitzgerald analyst Colin Canfield initiated coverage of five Government Technology & Space, or ...

It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...

In a report released today, Deepak Mathivanan from Cantor Fitzgerald maintained a Hold rating on Expedia (EXPE – Research Report), with a price ...

A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...

Cantor Fitzgerald lowered the firm’s price target on Molina Healthcare (MOH) to $356 from $406 and keeps an Overweight rating on the shares.

Cantor Fitzgerald reaffirmed its Overweight rating on Neurocrine Biosciences stock (NASDAQ:NBIX) with a consistent price target of $170.00. Currently trading at $150.51, the stock has shown strong ...

Howard Lutnick, a billionaire banker poised to run the Department of Commerce, has deep ties to the crypto industry. But he ...

Analysts at Cantor Fitzgerald lowered their FY2025 EPS estimates for shares of PTC Therapeutics in a report released on ...

Lutnick is CEO of Cantor Fitzgerald, previous owner of Cantor Gaming. The company reportedly violated state and federal ...

Cantor Fitzgerald boosted their FY2025 earnings per share estimates for shares of Palantir Technologies in a report released on Tuesday, February 4th. Cantor Fitzgerald analyst T. Blakey now ...